Back to Journals » OncoTargets and Therapy » Volume 15
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,390 | Dovepress* | 4,050+ | 109 | 4,159 | |
PubMed Central* | 340 | 123 | 463 | ||
Totals | 4,390 | 232 | 4,622 | ||
*Since 17 October 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar